Vertex Pharmaceuticals
VRTX
VRTX
689 hedge funds and large institutions have $41B invested in Vertex Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 276 increasing their positions, 242 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $39.3B → $41B (+$1.68B)
0.28% less ownership
Funds ownership: 95.02% → 94.74% (-0.28%)
4% less call options, than puts
Call options by funds: $294M | Put options by funds: $306M
Holders
689
Holding in Top 10
16
Calls
$294M
Puts
$306M
Top Buyers
| 1 | +$339M | |
| 2 | +$204M | |
| 3 | +$149M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$137M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$127M |
Top Sellers
| 1 | -$327M | |
| 2 | -$291M | |
| 3 | -$208M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$183M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$158M |